The United States Medical Licensing Examination (USMLE) is a three-step examination program for medical licensure in the United States sponsored by the Federation of State Medical Boards (FSMB) and the National Board of Medical Examiners (NBME) that physicians with a medical degree and international medical graduates must pass after successful completion of medical training to receive their medical license and begin practicing medicine.
States may enact additional testing and/or licensing requirements. Physicians with a Doctor of Osteopathic Medicine (DO) degree must pass either the USMLE or the Comprehensive Osteopathic Medical Licensing Examination (COMLEX) exam for medical licensure.
The USMLE assesses a physician's ability to apply knowledge, concepts, and principles, and to determine fundamental patient-centered skills that are important in health and disease and that constitute the basis of safe and effective patient care. Examination committees composed of medical educators and clinicians from across the United States and its territories create the examination materials each year. At least two committees critically appraise each test item or case, revising or discarding any materials that are in doubt. The program intends to provide state medical boards in the United States with a common examination for all licensure applicants. However, as of 2021, physicians with a D.O. degree do not require it for licensure.
The USMLE was first designed in the late 1980s and introduced during the period 1992 to 1994. The program replaced the NBME Part Examination program and the FSMB's Federation Licensing Examination (FLEX) program, which were the widely accepted medical licensing examination programs at the time in the medical profession. In 2004, a clinical-skills examination was added to Step 2 of the USMLE (USMLE Step 2 Clinical Skills, and beginning with the medical school graduating class of 2005, students have been required to pass it in order to be licensed. In 2005, a clinical-skills component was also added to the examination program of the Comprehensive Osteopathic Medical Licensing Examination of the National Board of Osteopathic Medical Examiners, which physicians with the D.O. degree take to achieve medical licensure in the United States. On May 26, 2020, in response to the COVID-19 pandemic, the USMLE "suspended Step 2 CS test administrations for the next 12-18 months." On January 26, 2021, the USMLE announced that the work to relaunch a modified form USMLE Step 2 CS had been discontinued citing rapidly evolving medical education and changes in other standardized exams, like computer-based simulations in Step 3, that would supplement medical students' education in place of Step 2 CS.
USMLE Step 1 assesses whether medical school students or graduates understand and can apply important concepts of the basic sciences to the practice of medicine. Step 1 ensures mastery of not only the sciences that provide a foundation for the safe and competent practice of medicine in the present, but also the scientific principles required for maintenance of competence through lifelong learning. Step 1 is constructed according to an integrated content outline that organizes basic science material along two dimensions: system and process. It includes the following subjects: Anatomy, Behavioral Sciences, Biochemistry, Microbiology, Pathology, Pharmacology, Physiology, and interdisciplinary topics such as nutrition, genetics, and aging.
USMLE Step 2 Clinical Knowledge is a standardized test that assesses a candidate's ability to apply medical knowledge, skills, and understanding of clinical science essential for the provision of patient care under supervision covering topics in various medical disciplines: internal medicine, obstetrics and gynecology, pediatrics, psychiatry and surgery.
The USMLE Step 2 Clinical Skills exam was a standardized test that assessed candidates on their ability to gather information from patients, perform physical examinations, and communicate their findings to patients and colleagues. It was discontinued in 2021.
USMLE Step 3 is the final exam in the USMLE sequence and assesses whether medical school students or graduates can apply medical knowledge and understanding of biomedical and clinical science essential for the unsupervised practice of medicine, with emphasis on patient management in ambulatory settings. Graduates of US medical schools typically take this exam at the end of the first year of residency. Examinees are tested on the following subjects: central nervous system, eye/ear/nose/mouth/throat, respiratory system, circulatory system, digestive system, behavioral/emotional disorders, musculoskeletal system, skin/subcutaneous tissue, endocrine/nutrition/metabolic disorders, kidneys/urinary tract, reproductive system, pregnancy/childbirth, neonate/childhood illnesses, blood and blood-forming organs, infectious/parasitic diseases, injuries/wound/toxic effects/burns, and health maintenance issues.
|Years of data||U.S. M.D. medical school examinees||(US 1st-time takers)||U.S. D.O. osteopathic medical school examinees||(US DO 1st time)||Examinees from Non-US/Canadian Schools||(Int'l 1st time)|
|Step 2 CK||(2018-2019)||97%||98%||97%||97%||82%||87%|
The USMLE Step 1 and Step 2 CK exams can be taken at Prometric test centers worldwide. The Step 3 can only be taken in the United States.
The USMLE Step 1 is typically taken during a student's second year of medical school. The one-day exam tests them on basic science principles, including behavioral science, microbiology, physiology, and anatomy. The exam announced a move to a pass/fail model on February 12, 2020, along with other changes due to an attempt by the Federation of State Medical Boards (FSMB) and the National Board of Medical Examiners (NBME) to balance focus between exams and actual coursework.
USMLE mean and median scores have increased significantly in the past decades—so much so that the testing board had to increase the score it takes to pass. A large part of the increase was attributed in empirically-based research articles to performance improvement factors such as using a question bank to prepare for the test.
A study from 2016 showed little to no correlation between MCAT scores and USMLE Step 1 scores, as well as little to no correlation between MCAT scores and the NBME scores. However, since the 82 students on whom this study was conducted all attended the same medical school, the usefulness of these results in the broader medical school population may be of limited value.
Furthermore, research conducted on students between 1998 and 2004, although outdated, and conducted on an undisclosed number of students, was conducted on a longer timeline, and shows that the Biological Science (BS) section of the MCAT did indeed predict better performance on the USMLE Step 1, but not any other section, and found that grade point average in undergraduate science courses is a strong predictor of performance on the USMLE Step 1 and Step 2 exams, and that the Biological Science section of the MCAT, but not any other section, predicted USMLE Step 1 and Step 2 exam performance, though this information is outdated, and unclear of whether this was also only conducted at a single institution or more than one, making this study's results of limited value. The same study claims that the selectivity of undergraduate institution is also a predictor of step 1 and step 2 performance, even when controlling for undergraduate GPA and MCAT score.
The USMLE was met with criticism for their lack of adaptability during the COVID-19 pandemic. The criticism was two-fold: First, for the mishandling and poor communication of exam cancellations by both USMLE program administrators and the third-party exam administrator, Prometric. Second, the pandemic crisis exacerbated existing resentment towards the high-stakes nature of the exam: namely, several students and physicians were upset that the USMLE refused to move up the 2022 deadline of making Step 1 into a pass or fail exam.
A study conducted in 2020 showed differences in USMLE Step 1 scores attributable to race and ethnicity, with lower mean scores for self-identified Black, Asian, and Hispanic examinees when compared with self-identified White examinees. The mean effect was larger when comparing Caucasian applicants (223) with Black and Hispanic applicants (216). Depending on the threshold score, an African American was 3-6x less likely to be offered an interview." "61% of minority applicants were accepted into an orthopaedic residency versus 73% of White applicants. White and Asian applicants and residents had higher USMLE Step 1. White applicants and matriculated candidates had higher odds of Alpha Omega Alpha membership compared with Black, Hispanic, and other groups.  In year 2020, the American Academy of Family Physicians and the Association of American Medical Colleges expressed their support for changing Step 1 to pass or fail, in part to reduce racial bias.
The US Medical Licensing Examinations have received criticism due to their high cost. As of 2020, the USMLE charges:
As part of a broader public plea for systemic changes to the improper use of USMLE STEP exams, STAT wrote that this "multimillion-dollar industry has exploited the opportunity to extract thousands of dollars from already overly indebted students. Registering for STEP exams test cost $645-$1300, while Step preparation materials and courses run much higher."
|Wikibooks has a book on the topic of: USMLE Step One Review|